Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan

BACKGROUND: The cost of schizophrenia in Japan is high and new long-acting injectable (LAI) antipsychotics might be able to reduce costs by causing a reduction of hospital stays. We aim to estimate budget effects of the introduction of a new 1-month LAI, paliperidone palmitate, in Japan. METHODS: A...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinicoecon Outcomes Res
Hlavní autoři: Mahlich, Jörg, Nishi, Masamichi, Saito, Yoshimichi
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4447166/
https://ncbi.nlm.nih.gov/pubmed/26045674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S85514
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky